PT - JOURNAL ARTICLE AU - Johnston, Keira JA AU - Ward, Joey AU - Ray, Pradipta R AU - Adams, Mark J AU - McIntosh, Andrew M AU - Smith, Blair H AU - Strawbridge, Rona J AU - Price, Theodore J AU - Smith, Daniel J AU - Nicholl, Barbara I AU - Bailey, Mark E.S TI - Sex-Stratified Genome-Wide Association Study of Multisite Chronic Pain in UK Biobank AID - 10.1101/2020.06.25.20140087 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.25.20140087 4099 - http://medrxiv.org/content/early/2020/06/26/2020.06.25.20140087.short 4100 - http://medrxiv.org/content/early/2020/06/26/2020.06.25.20140087.full AB - Chronic pain is highly prevalent worldwide and imparts significant socioeconomic and public health burden and is more prevalent in women than in men. Factors that influence susceptibility and mechanisms of chronic pain development, are not fully understood.To investigate sex differences in chronic pain, we carried out a sex-stratified genome-wide association study of Multisite Chronic Pain (MCP), a derived chronic pain phenotype in UK Biobank. Genetic correlations between MCP in each sex and a range of psychiatric, autoimmune, and anthropometric phenotypes were examined. The relationship between female and male MCP, and chronic widespread pain was investigated using polygenic risk scoring. Expression of sex-specific MCP-associated loci in a range of tissues was examined using GTEx, and separately in neural and non-neural human tissues with assessment for dorsal-root ganglion (DRG) enrichment. For genes enriched for neural-tissue expression the full GTEx database was queried for sex-differential gene expression in CNS regions, and for high expression in sex-specific tissues. Expression in neural mouse tissue was also examined for orthologs of these genes.A total of 123 SNPs at five independent loci were significantly associated with MCP in men. In women, a total of 286 genome-wide significant SNPs at ten independent loci were discovered. Meta-analysis of sex-stratified GWAS output found 87 independent SNPs to be significantly associated with MCP. We found sex-specific MCP-associated genes, with 31 genes and 37 genes associated with female and male MCP respectively and one gene associated with MCP in both sexes (DCC).We found evidence for sex-specific pleiotropy and risk for MCP was found to be associated with chronic widespread pain in a sex-differential manner. Male and female MCP were highly genetically correlated, but at rg significantly less than 1. All 37 male MCP-associated genes and all but one of 31 female MCP-associated genes were found to be expressed in the DRG, and many showed elevated expression in sex-specific tissues.Overall, findings indicate sex differences in chronic pain at the SNP, gene and transcriptomic level, and highlight possible sex-specific pleiotropy for MCP. Results support the proposition of a strong nervous-system component to chronic pain in both sexes, emphasise the importance of the DRG, and indicate specific loci which may play a specialised role in nociception.Competing Interest StatementThe authors have declared no competing interest.Funding StatementRJS is supported by a UKRI Innovation- HDR-UK Fellowship (MR/S003061/1). JW is supported by the JMAS Sim Fellowship for depression research from the Royal College of Physicians of Edinburgh (173558). KJAJ is supported by an MRC Doctoral Training Programme Studentship at the Universities of Glasgow and Edinburgh. DJS acknowledges the support of a Lister Prize Fellowship (173096) and the MRC Mental Health Data Pathfinder Award (MC_PC_17217). M.J.A. and A.M.M. are supported by Pathfinder Award MC_PC_17209 and by Wellcome Trust Grant 104036/Z/14/Z. TJP is supported by a National Institute of Neurological Disorders and Stroke (Bethesda) grant (R01NS102161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The UK Biobank study was approved by the National Health Service National Research Ethics Service (ref.11/NW/0382) and all participants provided written informed consent. UK Biobank analyses were carried out under approved application 6553. Details on ethics for the collection of hDRG data used here can be found in full in the original publication [10.1097/j.pain.0000000000001217], excerpt "Informed consent for human tissue sources were obtained by Anabios, Inc (San Diego, CA). This work was approved by The University of Texas at Dallas Institutional Review Board (MR 15-237)". In the current manuscript all data are secondary.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesUK Biobank data are available upon application to UK Biobank. GWAS summary statistic outputs will be made available through University of Glasgow Enlighten upon manuscript publication and upon request. Mouse transcriptomic data are freely accessible at mousebrain.org.